View profile

🔊 Your guide to AI: May 2021

Nathan Benaich, Air Street Capital
Nathan Benaich, Air Street Capital
Hi everyone,
Following last week’s May 2021 newsletter, here is the audio edition on SpotifyAnchor (browser-based), or Apple. Here is the RSS.
This week, we announced the acquisition of AI-first precision medicine leader Allcyte by Exscientia, a leading AI-first drug design company. Read more on why this is a big deal in my Twitter thread, which also marks the first exit for Air Street Capital.
Thanks too for sharing our Research Assistant job ad for State of AI Report 2021 as well as the database (🥂 to reaching 💯 entries today!).
See you in 3 weeks for the next issue of Your guide to AI: June 2021.
As always, thanks for hitting forward to a couple of friends 🙏

Signing off, 
Nathan Benaich, 20 June 2021
Air Street Capital is a venture capital firm investing in AI-first technology and life science companies. We’re an experienced team of investors and founders based in Europe and the US with a shared passion for working with entrepreneurs from the very beginning of their company-building journey.
Did you enjoy this issue? Yes No
Nathan Benaich, Air Street Capital
Nathan Benaich, Air Street Capital @nathanbenaich

Monthly analysis of AI technology, geopolitics, research, and startups.

In order to unsubscribe, click here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Created with Revue by Twitter.